Madrigal Pharmaceuticals (MDGL) Free Cash Flow Growth (5y) (2015 - 2026)
Powered by 
Analysis
Madrigal Pharmaceuticals (MDGL) Free Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.37 Bn | 130.52 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.18 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.33 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.92 Bn | 52.78 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.48 Bn | 32.17 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.38 Bn | 26.22 Bn | 358.27 Mn |
| 10 | Madrigal Pharmaceuticals | 15.74 Bn | 14.90 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.20% |
| Mar 31, 2026 | -31.55% |
| Dec 31, 2025 | -19.35% |
| Sep 30, 2025 | 29.56% |
| Jun 30, 2025 | -14.16% |
| Mar 31, 2025 | -23.60% |
| Dec 31, 2024 | -51.44% |
| Sep 30, 2024 | -43.03% |
| Jun 30, 2024 | -63.56% |
| Mar 31, 2024 | -87.11% |
| Dec 31, 2023 | -66.79% |
| Sep 30, 2023 | -74.62% |
| Jun 30, 2023 | -69.67% |
| Mar 31, 2023 | -57.62% |
| Dec 31, 2022 | -57.35% |
| Sep 30, 2022 | -64.20% |
| Jun 30, 2022 | -49.20% |
| Mar 31, 2022 | -67.65% |
| Dec 31, 2021 | -55.59% |
| Sep 30, 2021 | -37.61% |